Medolac Laboratories

With an unmet global need, Medolac has developed a platform that is leaner, and smarter and designed to serve the world. We are a proven team of passionate people whose goal is to improve the lives of infants everywhere through disruptive products.

Medolac is a Public Benefit company, committed to improving access to life-changing human milk based nutritional and therapeutic products. The first commercially sterile human donor milk was developed by Medolac and is currently being used by hospital Neonatal Intensive Care Units (NICUs) around the world.

Medolac's status as a Public Benefit Corporation was approved unanimously by its shareholders and ushers in a new era of social impact advocacy and investment in human milk banking. This new form of corporation allows Medolac Laboratories and its board to consider the balanced interests of a broad set of stakeholders affected by its business.

Medolac's social purposes are to dramatically enhance access to safe, high quality human donor milk, particularly in clinical and post discharge settings, and to provide economic and social empowerment to human milk donors through cooperative membership with their milk bank. As a public benefit corporation, Medolac's corporate charter has expanded to encompass these social benefits. Public Benefit Corporation status is not only good for Medolac Laboratories but also for its stakeholders, including premature infants and mothers who benefit from membership in the Mothers Milk Cooperative, our partner milk bank - the first and only mother's milk bank cooperative owned and controlled by its members.

Medolac Laboratories headquartered in United States, North America, operates in the Health Care, Women's, Nutrition sector. With a team of 11-50 employees, Medolac Laboratories is actively contributing to advancements in Health Care. Discover more about their projects, partnerships, and impact on our platform.